Navigation Links
The top 10 misconceptions of life-science patents

Over the last 15 years in patent law, I have encountered many misconceptions about the process of obtaining and enforcing U.S. patents that cover life-science inventions.

The following is a list of some of the most common and most important misconceptions, surrounded by reality. Like most legal analysis, there are exceptions to any rule or guideline. I'm hop......

Full article >>> st prior art is always made of record.

Reality # 3: As a corollary to the second misconception, the reality is that the quality of the prior art search and examination varies significantly from one examiner to the next. At the end of the day, it really is the applicant's ultimate responsibility to ensure that all of the best prior art is of record, that the claims are......

Full article >>> to an office action rejecting or objecting to the application, an inventor may submit a Rule 132 declaration containing data and other information pertaining to the invention. The data and other information then become part of the application. More commonly, data and other information may be added to the specification of the parent application and filed as a Continuation-In-Part (CIP) application.......

Full article >>> s.

Reality # 10: Infringers infringe claims, not the specifications. However, fewer claims will be needed if they are well-drafted and strategic. During litigation, you can never have enough valid claims. The cost of litigating patents is enormous and growing. In comparison, the cost of obtaining additional claims is "de minimus." Numerous strategic claims also can be an effective ......

Full article >>>
'"/>

Source:wistechnology.com By Christopher Rogers 07/22/06


Related biology technology :

1. A Midwest life-science odyssey comes full circle
2. A Midwest small-cap, life-science surprise package
3. Madison life-science firms agree to co-develop kidney product
4. Does Milwaukee need a life-science spark?
5. British, Wisconsin firms explore life-science opportunities together
6. Midwest large-cap life-science sector is solid in first quarter
7. The greatest life-science developments of 2004
8. Bio-Logic Systems, another Midwest life-science firm, flies under the radar
9. Midwest life-science company Perrigo globalizes under the radar
10. Supreme Court limits foreign reach of U.S. patents
11. Supreme Court ruling seen as blow to WARF stem cell patents
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... ANGELES , Jan. 23, 2017   Instrument ... Bio-Techne ( Minneapolis, MN ) the ... is the most authoritative newsletter tracking developments in ... market. "Bio-Techne consistently achieved outstanding technical, ... Tanya Samazan, Managing Editor of IBO. "In 2016, ...
(Date:1/24/2017)... 23, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... underwriting agreement with Rodman & Renshaw, a unit of ... book running manager and representative of several underwriters, under which ... commitment basis a minimum of 2,105,264 shares of common ... a minimum of 1,052,632 shares of common stock of ...
(Date:1/23/2017)... NEW YORK , Jan. 23, 2017  Spherix ... development company committed to the fostering of technology and ... its active patent infringement lawsuits. Anthony ... we enter 2017, we will continue to communicate with ... Equitable IP and our due diligence on other patent ...
(Date:1/23/2017)... CALGARY , Jan. 23, 2017 /PRNewswire/ - Resverlogix ... preliminary results from the New Zealand ... impaired patients. The data showed remarkable results in reducing ... versus healthy control patients. It is believed that this ... direct connection of this type can be made between ...
Breaking Biology Technology:
(Date:12/20/2016)... 2016 The rising popularity of mobility ... is stoking significant interest in keyless access systems. ... low energy (BLE), biometrics and near-field communication (NFC) ... of wireless technologies in the automotive industry. This ... access systems opens the market to specialist companies ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/16/2016)... 16, 2016 Research and Markets has announced ... Global Forecast to 2021" report to their offering. ... The biometric vehicle access ... a CAGR of 14.06% from 2016 to 2021. The market is ... to reach 854.8 Million by 2021. The growth of the biometric ...
Breaking Biology News(10 mins):